Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine IV-PCA versus sufentanil IV-PCA and continuous iliac fascia block after hip replacement
ChiCTR2300069632Phase 4Not yet recruiting
- Sponsor
- Gansu Provincial People's Hospital
- Start
- Mar 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine, sufentanil and tramadol in postoperative pain (3 arms), sponsored by Gansu Provincial People's Hospital. Primary endpoint: Pain VAS score. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
esketaminesufentaniltramadol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300069632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069632.